Progressive Care Announces November 2020 Results, Reports Strong Prescriptions and Covid-19 Rapid Testing Sales

Learn more

About Progressive Care Inc.

At Progressive Care, our mission is to improve every step of the patient journey by adding value to prescribers, caregivers, and patients in a seamless manner. Through the implementation of proven processes, we empower medical practices to achieve the highest standards of personalized care. Learn more about us

Products, services and their markets

pharmco-rx-pharmacy

At PharmCo, we take pride in being more than your average pharmacy. We are committed to providing effective, timely, and affordable medications to our patients and the surrounding communities, but our devotion to this mission goes above and beyond.
Learn more about our pharmacy operations

ClearMetrx

ClearMetrX is a full-stack reporting platform that simplifies data analytics for physicians, MSO organizations, 340B entities, and pharmacies.
Learn more about our data management solutions

Releases

Progressive Care Announces November 2020 Results, Reports Strong Prescriptions and Covid-19 Rapid Testing Sales
January 7, 2021
Progressive Care Completes Move to New Facility, Begins Expansion Into Long-Term Care Pharmacy Market
December 23, 2020
Progressive Care, Inc. Announces Results of Special Meeting
December 17, 2020

Events

Progressive Care, Inc. Announces Results of Special Meeting
December 17, 2020
Progressive Care Leadership Announces Shareholder Conference Call and Business Update on December 7th, 2020
December 3, 2020
Progressive Care Partners with DeliverSTAT to Support and Expand Rapidly Growing Prescription Delivery Service
September 21, 2020

Earnings

Progressive Care Reports Positive Q3 EBITDA and Increased Margins
November 17, 2020
Progressive Care Reports Q2 2020 Financials: Sales Up 32%, Over $2M in Cash on Hand
August 16, 2020
Progressive Care Reports Q1 Performance, Net Sales Surpass $9 Million Amid COVID-19 Impact
May 18, 2020
News Releases
Progressive Care Announces November 2020 Results, Reports Strong Prescriptions and Covid-19 Rapid Testing Sales
MIAMI, FL – January 8, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the month of November 2020.
January 7, 2021
Progressive Care Completes Move to New Facility, Begins Expansion Into Long-Term Care Pharmacy Market
Miami, FL – December 23, 2020 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce that the Company has completed its move into its new 11,000 sq ft pharmacy space in Hallandale Beach, FL.
December 23, 2020
Progressive Care, Inc. Announces Results of Special Meeting
MIAMI, FLORIDA - December 17, 2020 - On December 14, 2020, Progressive Care, Inc. (the “Company”) held a special meeting of its stockholders (the “Special Meeting”). The record date for stockholders entitled to notice of, and to vote at, the Special Meeting was October 23, 2020. At the close of business on that date, the Company had 470,272,862 shares of common stock, par value $0.0001 (“Common Stock”) outstanding and 51 shares of Series A Super-Voting preferred stock (“Preferred Stock”) outstanding, and entitled to be voted at the Special Meeting. At the Special Meeting, the following four proposals were submitted to the Company’s stockholders:
December 17, 2020
Progressive Care Announces October Growth in Net Revenues as COVID-19 Testing Ramps Up
MIAMI, FL – December 7, 2020 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the month of October, which featured a strong jump in operating margins, significant sequential monthly growth in net revenues, and the establishment of sales growth related to rapid results COVID-19 testing.
December 7, 2020
Progressive Care Leadership Announces Shareholder Conference Call and Business Update on December 7th, 2020
‍On the call, RXMD management will answer pre-submitted questions and discuss details regarding the recently filed proxy statement.MIAMI, December 3nd 2020 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, December 7th, 2020.
December 3, 2020
Progressive Care Announces Confidential Submission of Draft Registration Statement
MIAMI, FL – December 2nd, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”) is pleased to announce that on November 9th it confidentially submitted a draft Registration Statement on Form S-1 to the Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to take place after the SEC completes its review process, subject to market and other conditions.
December 2, 2020
Progressive Care Reports Positive Q3 EBITDA and Increased Margins
MIAMI, FL – November 17, 2020 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the three months ended September 30, 2020, including strong topline and bottom line growth, positive EBITDA, increased margins, and continued strong cash resources on hand at the close of the quarter.
November 17, 2020
Progressive Care Announces Nine-Month Sales of $30.2 Million, Increase of 31% And Updates September Performance
MIAMI, FL – November 4, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce preliminary topline performance data for the three- and nine month periods ended September 30, 2020, reflecting strong overall growth in sales and prescriptions, breakout expansion in the Company’s 340B segment, and anticipated progress towards the launch of telemedicine services before year-end.
November 5, 2020
Progressive Care Announces New Partnership with MyApps, Discontinues Plans To Acquire The Company
MIAMI, FL – October 29, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced that the Letter of Intent (the “LOI”) entered into on September 1, 2020, for the Company to acquire substantially all of MyApps Corp. (“MyApps”) has been terminated by the companies.
October 29, 2020
Progressive Care Announces Permanent Chief Executive Officer and New Chief Financial Officer
Progressive Care Inc. is pleased to announce that its Board of Directors has appointed Alan Jay Weisberg as Chief Executive Officer
October 27, 2020
Investors' Presentation

$RXMD is Available on Major Trading Platforms

Progressive Care Inc. is a healthcare management company trading on OTCQB Markets. We encourage visitors to do proper research before investing in OTC Stocks and Penny Stocks. This is not a penny stock recommendation. Progressive Care Inc. main goal is to share relevant and accurate information related to company operations. You can see the full Progressive Care Inc. Audited Annual Report for Fiscal Year Ending in 2019 here.

ameritrade-logo

Ameritrade

Get Started